GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oryzon Genomics SA (STU:ORN) » Definitions » E10

Oryzon Genomics (STU:ORN) E10 : €-0.10 (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Oryzon Genomics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Oryzon Genomics's adjusted earnings per share data for the three months ended in Sep. 2024 was €-0.020. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-0.10 for the trailing ten years ended in Sep. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-03-17), Oryzon Genomics's current stock price is €2.875. Oryzon Genomics's E10 for the quarter that ended in Sep. 2024 was €-0.10. Oryzon Genomics's Shiller PE Ratio of today is .


Oryzon Genomics E10 Historical Data

The historical data trend for Oryzon Genomics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oryzon Genomics E10 Chart

Oryzon Genomics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Oryzon Genomics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -0.10

Competitive Comparison of Oryzon Genomics's E10

For the Biotechnology subindustry, Oryzon Genomics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oryzon Genomics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oryzon Genomics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Oryzon Genomics's Shiller PE Ratio falls into.



Oryzon Genomics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Oryzon Genomics's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.02/123.1207*123.1207
=-0.020

Current CPI (Sep. 2024) = 123.1207.

Oryzon Genomics Quarterly Data

per share eps CPI Adj_EPS
201412 0.000 100.251 0.000
201503 -0.026 99.474 -0.032
201506 0.027 101.138 0.033
201509 -0.014 99.559 -0.017
201512 -0.023 100.268 -0.028
201603 -0.026 98.638 -0.032
201606 -0.075 100.333 -0.092
201609 -0.049 99.737 -0.060
201612 -0.047 101.842 -0.057
201703 -0.046 100.896 -0.056
201706 -0.043 101.848 -0.052
201709 -0.035 101.524 -0.042
201712 -0.039 102.975 -0.047
201803 -0.031 102.122 -0.037
201806 0.047 104.165 0.056
201809 -0.029 103.818 -0.034
201812 -0.020 104.193 -0.024
201903 -0.031 103.488 -0.037
201906 -0.014 104.612 -0.016
201909 -0.022 103.905 -0.026
201912 -0.021 105.015 -0.025
202003 -0.026 103.469 -0.031
202006 -0.004 104.254 -0.005
202009 -0.017 103.521 -0.020
202012 -0.021 104.456 -0.025
202103 -0.034 104.857 -0.040
202106 0.015 107.102 0.017
202109 -0.026 107.669 -0.030
202112 -0.040 111.298 -0.044
202203 -0.031 115.153 -0.033
202206 0.006 118.044 0.006
202209 -0.010 117.221 -0.011
202212 -0.041 117.650 -0.043
202303 -0.029 118.948 -0.030
202306 0.018 120.278 0.018
202309 -0.020 121.343 -0.020
202312 -0.027 121.300 -0.027
202403 -0.019 122.762 -0.019
202406 0.002 124.409 0.002
202409 -0.020 123.121 -0.020

Add all the adjusted EPS together and divide 10 will get our e10.


Oryzon Genomics  (STU:ORN) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Oryzon Genomics E10 Related Terms

Thank you for viewing the detailed overview of Oryzon Genomics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Oryzon Genomics Business Description

Traded in Other Exchanges
Address
Sant Ferran 74, Cornellà de Llobregat, Barcelona, ESP, 08940
Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics. It is engaged in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cancer and neurodegenerative diseases.